Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Wow Great News Today !

<< Previous

Bullboard Posts

Next >>

Comment by 2b7f6fabon Nov 13, 2020 6:52pm

242 Views

Post# 31899955

RE:Wow Great News Today !

Yea a buyout this soon is a bit of a stretch. More importantly, if the FDA grants either FTA or BTD later this month then I would expect marketing approval for TLT1433 within 12 months. FTA will be a moon shot, marketing approval will be a slingshot around Uranus on its way to Alpha Centauri.

<< Previous

Bullboard Posts

Next >>

This battery metals stock is on a path to the global stage